Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000301
Status:
COMPLETED
Last Update Posted:
2016-07-11
First Post:
1999-09-20
Brief Title:
Rapid Evaluation of Amantadine for Treatment of Cocaine AbuseDependence - 4
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Study Overview
Official Title:
Rapid Evaluation of Cocaine Pharmacotherapies Amantadine
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to empirically test a series of medications to 1 determine each medications efficacy in treatment of cocaine abusedependence 2 find most effective dose range for each medication In this study amantadine is tested
Detailed Description:
16-week participation plus a 2 weekk lead-in period Participants are assigned randomly to placebo or amantadine Participants attend group meeting 3 timesweek
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P50-09260-4 | US NIH GrantContract | None | httpsreporternihgovquickSearchP50DA009260 |
| P50DA009260 | NIH | None | None |